Sickle cell disease is an inherited blood disorder that affects about one in 12 African Americans. During National Minority Health Month, learn more about NCATS’ work on a potential treatment.
NCATS researchers develop new technologies that can be transferred — through collaborations and licenses — to others for further research, development and commercialization.
NCATS is seeking innovative and dedicated professionals to join its dynamic staff. Learn more about our current job opportunities.
Collaborators from NCATS and NCI published a study demonstrating the system’s power to find drug combinations to treat a type of blood cancer.
How is NCATS advancing translational research? Learn more about the Center's work and some of its early successes.
MORE CENTER NEWS
Regulatory agencies face record applications for rare disease therapies.
Connecting researchers and industry to find new treatments for patients.
- Notice of NIH Improving the Financial Conflict of Interest (FCOI) Module for Submission of Financial Conflict of Interest Reports to the NIH
- Notice of NIH HeLa Genome Sequence Data Submission and Access Policy
- NIH Will Open the Research Performance Progress Report (RPPR) for All Type 5 Non-SNAP Progress Reports on April 25, 2014
- More Funding & Notices...
- Active Skepticism: Beyond the IOM’s CTSA Report • Science Translational Medicine
- Wisconsin Research Shows Green Space Keeps You from Feeling Blue • University of Wisconsin School of Medicine and Public Health
- IU Bloomington Faculty Awarded Indiana Clinical and Translational Sciences Grants • Indiana University
- More News & Events...